Obesity and Lung Disease: A Guide to Pathophysiology, Evaluation, and Management (Respiratory Medicine)

★★★★★ 4.7 44 reviews

US$58.63
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by leatherwoodandsilver.com
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$58.63
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Jul 16
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by leatherwoodandsilver.com
Free 30-day returns Details

Product details

Management number 231920462 Release Date 2026/06/18 List Price US$58.63 Model Number 231920462
Category

This new edition provides a fully updated guide to obesity’s relation to lung disease. Over forty percent of the U.S. population is obese, and obesity is increasing in much of the world. Obesity has a major impact on health conditions such as diabetes and cardiovascular disease. The effects of obesity on lung disease have drawn increasing attention in recent years. Furthermore, the COVID pandemic has dramatically illustrated how obesity affects respiratory disease, constitutes a major risk factor for COVID-19, and presents challenges to pulmonary care in the ICU. Obesity changes physiology, immune and metabolic function, and is associated with changes in diet and the microbiome, all of which combine to have a major impact on the pathogenesis of respiratory diseases. Obesity is thus a risk factor for many respiratory diseases such as asthma, pulmonary hypertension, thromboembolic disease, obstructive sleep apnea and ARDS. Obesity also complicates the management of manyother respiratory diseases and conditions such as COPD, thromboembolic disease, and the care of the critically ill patient.The objectives of this book are three-fold: To review how physiological, immune and metabolic factors might contribute to lung disease. To discuss the impact of obesity on common lung diseasesTo outline important considerations in the management of critically ill obese patients.There have been major advances in our understanding of the relationship between obesity and lung disease since the first edition in 2013, in addition to the major lessons learned about the importance of obesity during the COVID-19 pandemic. This has led to the addition of eight new chapters on topics such as, the microbiome, lung transplant, and COVID-19 in the ICU.This is an ideal guide for all clinicians taking care of patients with pulmonary and critical care diseases, as well as basic and translational scientists interested in how obesity affects respiratory health. Read more

ISBN10 3031526953
ISBN13 978-3031526954
Edition Second Edition 2024
Language English
Publisher Humana
Dimensions 9.5 x 0.93 x 6.43 inches
Item Weight 7.6 ounces
Print length 420 pages
Publication date May 28, 2024

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.7 out of 5
★★★★★
44 ratings | 18 reviews
How item rating is calculated
View all reviews
5 stars
86% (38)
4 stars
2% (1)
3 stars
1% (0)
2 stars
1% (0)
1 star
10% (4)
Sort by

There are currently no written reviews for this product.